New York A 4604: Relates to the time election day workers must be at poll sites to prepare for the opening of polls

Bill Text

Bill Search and Legislative Information | New York State Assembly 

• 

• 

• 

• 

• 

• 

• 

• 

 Skip to main content 

 New York State Assembly

 Speaker Carl E. Heastie

 --> 
 --> 

 --> 

• 
 Assembly Members 

• 
 Legislative Info 

• 
 Public Hearings 

• 
 Speaker's Press 

• 
 Assembly Reports 

• 
 Committees & More 

• Bill Search Home
• Laws
• Legislative Calendar
• Public Hearing Schedule
• Assembly Calendars
• Assembly Committee Agenda 

 Javascript must be enabled to properly view this page. 

 Bill No.: 

• Summary 
• Actions 
• Committee&nbspVotes 
• Floor&nbspVotes 
• Memo 
• Text 
• LFIN 
• Chamber&nbspVideo/Transcript 
A04604 Summary:

BILL NOA04604 

&nbsp

SAME ASSAME AS S00371

&nbsp

SPONSORSimon (MS)

&nbsp

COSPNSRCook, Dinowitz, Hunter, Magnarelli, Ramos, Rivera, Rosenthal, Reyes, Cruz, Epstein, Colton, Paulin,
 Gonzalez-Rojas, Smith, Forrest, Jackson, Simone, Hevesi, Lunsford, Levenberg, Santabarbara,
 Lupardo, DeStefano, Davila, Clark, Burdick, Steck, Shrestha, Seawright, Brown K, Shimsky, Pheffer
 Amato, Bores, McDonough, Jacobson, Kassay, Maher, Griffin, Stern

&nbsp

MLTSPNSRButtenschon

&nbsp

Add §280-d, Pub Health L; amd §6808, Ed L

&nbsp

Creates a wholesale prescription drug importation program which complies with federal standards and regulations for the purpose of generating substantial savings for consumers.

Go to top A04604 Actions:

BILL NOA04604 

&nbsp

02/04/2025referred to ways and means

04/14/2025reference changed to higher education

01/07/2026referred to higher education

Go to topA04604 Committee&nbspVotes:

Go to topA04604 Floor&nbspVotes:

There are no Assembly votes for this bill in this legislative session.

Go to topA04604 Text:

 STATE OF NEW YORK
 ________________________________________________________________________

 4604

 2025-2026 Regular Sessions

 IN ASSEMBLY

 February 4, 2025
 ___________

 Introduced by M. of A. SIMON, COOK, DINOWITZ, HUNTER, MAGNARELLI, RAMOS,
 RIVERA, ROSENTHAL, REYES, CRUZ, EPSTEIN, COLTON, PAULIN, GONZALEZ-RO-
 JAS, SMITH, FORREST, JACKSON, SIMONE, HEVESI, LUNSFORD, LEVENBERG,
 SANTABARBARA, LUPARDO, DeSTEFANO, DAVILA, CLARK, BURDICK, STECK,
 SHRESTHA, SEAWRIGHT, K. BROWN, SHIMSKY, PHEFFER AMATO, BORES, McDO-
 NOUGH -- Multi-Sponsored by -- M. of A. BUTTENSCHON -- read once and
 referred to the Committee on Ways and Means

 AN ACT to amend the public health law and the education law, in relation
 to creating a wholesale prescription drug importation program

 The People of the State of New York, represented in Senate and Assem-
 bly, do enact as follows:

 1 Section 1. The public health law is amended by adding a new section
 2 280-d to read as follows:
 3 § 280-d. Wholesale prescription drug importation program. 1. As used
 4 in this section, the following terms shall have the following meanings:
 5 (a) "Wholesale prescription drug importation program" or "program"
 6 means the wholesale prescription drug importation program created under
 7 this section.
 8 (b) "Prescription drug wholesaler" means an entity authorized to
 9 acquire prescription drugs and sell or distribute them wholesale in the
 10 state.
 11 (c) "Approved wholesaler" means a prescription drug wholesaler author-
 12 ized to participate in the importation program under this section pursu-
 13 ant to approval by the state education department under section sixty-
 14 eight hundred eight of the education law.
 15 2. The commissioner, in consultation with the commissioner of educa-
 16 tion and other appropriate federal and state agencies, shall design a
 17 wholesale prescription drug importation program for the wholesale impor-
 18 tation of prescription drugs from Canada. The program design shall
 19 comply with applicable federal requirements, including 21 U.S.C. § 384,

 EXPLANATION--Matter in italics (underscored) is new; matter in brackets
 [ ] is old law to be omitted.
 LBD00949-01-5

 A. 4604 2

 1 and requirements regarding safety and cost savings. Under the program
 2 design:
 3 (a) prescription drugs shall only be acquired from Canadian
 4 prescription drug suppliers regulated and authorized under the laws of
 5 Canada or one or more Canadian provinces, or both;
 6 (b) only prescription drugs meeting the federal Food and Drug Adminis-
 7 tration's safety, effectiveness, misbranding, adulteration and other
 8 standards shall be imported under the program;
 9 (c) only prescription drugs expected to generate substantial savings
 10 for consumers in the state shall be imported;
 11 (d) the prescription drug is not:
 12 (i) a controlled substance as defined in 21 U.S.C. § 802;
 13 (ii) a biological product as defined in 42 U.S.C. § 262;
 14 (iii) an infused drug, including a peritoneal dialysis solution;
 15 (iv) an intravenously injected drug;
 16 (v) a drug that is inhaled during surgery;
 17 (vi) a drug which is a parenteral drug, the importation of which is
 18 determined by the United States Secretary of Health and Human Servi